These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998 [TBL] [Abstract][Full Text] [Related]
10. Clinical expression of organophosphate-induced delayed polyneuropathy in rats. Moretto A; Capodicasa E; Lotti M Toxicol Lett; 1992 Oct; 63(1):97-102. PubMed ID: 1412529 [TBL] [Abstract][Full Text] [Related]
11. Phenylmethanesulfonyl fluoride elicits and intensifies the clinical expression of neuropathic insults. Moretto A; Bertolazzi M; Capodicasa E; Peraica M; Richardson RJ; Scapellato ML; Lotti M Arch Toxicol; 1992; 66(1):67-72. PubMed ID: 1316117 [TBL] [Abstract][Full Text] [Related]
12. Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride. Lotti M; Caroldi S; Capodicasa E; Moretto A Toxicol Appl Pharmacol; 1991 Apr; 108(2):234-41. PubMed ID: 2017753 [TBL] [Abstract][Full Text] [Related]
13. Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells. Ehrich M; Correll L; Veronesi B Neurotoxicology; 1994; 15(2):309-13. PubMed ID: 7991219 [TBL] [Abstract][Full Text] [Related]
14. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE). Sogorb MA; González-González I; Pamies D; Vilanova E Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283 [TBL] [Abstract][Full Text] [Related]
15. Symposium introduction: retrospect and prospects for neuropathy target esterase (NTE) and the delayed polyneuropathy (OPIDP) induced by some organophosphorus esters. Johnson MK Chem Biol Interact; 1993 Jun; 87(1-3):339-46. PubMed ID: 8343991 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy. Lotti M; Moretto A; Zoppellari R; Dainese R; Rizzuto N; Barusco G Arch Toxicol; 1986 Oct; 59(3):176-9. PubMed ID: 2434058 [TBL] [Abstract][Full Text] [Related]
17. Reversible inhibition can profoundly mislead studies on progressive inhibition of enzymes: the interaction of paraoxon with soluble neuropathy target esterase. Barril J; Vilanova E Chem Biol Interact; 1997 Dec; 108(1-2):19-25. PubMed ID: 9463518 [TBL] [Abstract][Full Text] [Related]
18. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy. Milatovic D; Moretto A; Osman KA; Lotti M Chem Res Toxicol; 1997 Sep; 10(9):1045-8. PubMed ID: 9305588 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the neurotoxic effects of neuropathic organophosphorus compounds in adult zebrafish. Faria M; Fuertes I; Prats E; Abad JL; Padrós F; Gomez-Canela C; Casas J; Estevez J; Vilanova E; Piña B; Raldúa D Sci Rep; 2018 Mar; 8(1):4844. PubMed ID: 29555973 [TBL] [Abstract][Full Text] [Related]
20. The role of neurotoxic esterase (NTE) in the prevention and potentiation of organophosphorus-induced delayed neurotoxicity (OPIDN). Pope CN; Tanaka D; Padilla S Chem Biol Interact; 1993 Jun; 87(1-3):395-406. PubMed ID: 8343996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]